The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis

• Published in: Frontiers in medicine 2023-03, Vol.10, p.1130623-1130623
• Main Authors: Jiang, Shangxuan, Hao, Zhuolun, Qi, Wenli, Wang, Zhenxing, Zhou, Muran, Guo, Nengqiang
• Format: Article
• Language: English
• Subjects: Bimatoprost; cetirizine; hair loss; Latanoprost; Medicine; meta-analysis; prostaglandin analog
• ISSN: 2296-858X; 2296-858X
• DOI: 10.3389/fmed.2023.1130623

Prostaglandin analogs have been found to have more versatile uses: treatment of open-angle glaucoma, high intraocular pressure, vitiligo, and other treatments. And prostaglandin analogs have been found to have an important role in the hair growth cycle. However, prostaglandin analogs have not been sufficiently studied for hair (including hair, eyelashes, and eyebrows) regeneration. In this study, a systematic review and meta-analysis of topical prostaglandin analogs on hair loss was performed. The purpose of this meta-analysis is to determine the efficacy and safety of topical prostaglandin analogs for treating hair loss. We searched PubMed, Embase, and Cochrane Library databases comprehensively. Data were pooled using Review Manager 5.4.1, and subgroup analyses were performed if necessary. There were six randomized controlled trials included in this meta-analysis. All studies compared prostaglandin analogs with placebo, and one trial consisted of two sets of data. The results showed that prostaglandin analogs could significantly improve the hair length and density ( 0.001). As far as adverse events are concerned, there was no significant difference between the experimental group and the control group. In patients with hair loss, the topical prostaglandin analogs have better therapeutic efficacy and safety than placebo. However, the best dose and frequency of experimental treatment require further studies.